Genpharmasec Ltd (BSE: 531592) is a Mumbai, Maharashtra-based company in the Chemical Distribution industry. With a market capitalisation of ₹59 Cr, it ranks #3,722 by market cap among the 6,137 Indian listed companies on FinBizNet, and #37 of 84 in Chemical Distribution. At ₹0.99 (as of 25 Oct 2026), the share price is 46.2% below its 52-week high of ₹1.84 and 30.3% above its 52-week low of ₹0.76. The share price is down 44.1% over one year and down 2.9% over three months.
| Current Price | ₹0.99 |
|---|---|
| Market Cap | ₹59 Cr |
| BSE Code | 531592 |
| Sector | Industrials > Capital Goods > Trading Companies and Distributors |
| Sub-Industry | Trading Companies and Distributors > Chemical Distribution |
| P/E Ratio | 34.8 |
| Return on Equity | 0.86% |
| Return on Assets | -0.46% |
| 52-Week Range | ₹0.76 – ₹1.84 |
| 1-Year Price Change | -44.1% |
| 3-Month Price Change | -2.9% |
| Beta (1Y) | 0.73 |
| Headquarters | Mumbai, Maharashtra |
| Website | www.genpharmasec.com |
| Revenue | ₹45 Cr |
|---|---|
| Net Profit | ₹2 Cr |
| Net Margin | 3.5% |
| EPS (Basic) | ₹0.03 |
| Basis | standalone |
Figures in ₹ crore, parsed from the company's exchange filing (XBRL).
Genpharmasec Limited buys, sells, and distributes pharmaceutical activities and services in India. The company operates through two segments, Diagnostic Pharma Equipment, and Investment and Trading in Securities. The Diagnostic Pharma Equipment segment distributes state-of-the-art diagnostic equipment comprising of i-STAT analyzers and its cartridges used to analyze blood for test results in Intensive Care Units (ICUs) of hospitals. The Investment and Trading in Securities segment operates in secondary securities market. The company was formerly known as Generic Pharmasec Limited and changed its name to Genpharmasec Limited in October 2021. Genpharmasec Limited was incorporated in 1992 and is based in Mumbai, India.
1. Pharmaceuticals-This segment engages in the dealing of pharmaceutical products. 2. Trading in Securities-This segment trades in securities. 3. Un-Allocated-0 4. Segment Adjustment-0
1. Manufacturing & Processing-5.8% 2. Laboratory Testing-0.7% 3. Pharmaceuticals-93.5%
| Company | Market Cap | P/E | ROE | Latest Qtr Revenue | 1Y Change |
|---|---|---|---|---|---|
| Mmtc Ltd. | ₹8,480 Cr | 21.2 | 20.27% | ₹1 Cr | -25.7% |
| Refex Industries Limited | ₹3,526 Cr | 13.9 | 17.82% | ₹916 Cr | -35.9% |
| Fischer Chemic Ltd. | ₹1,926 Cr | 61 | 8.63% | ₹82 Cr | -73.9% |
| The Yamuna Syndicate Ltd | ₹799 Cr | 14.9 | 4.03% | — | -27.1% |
| MEGAMONT LIMITED | ₹767 Cr | 109.6 | — | — | +380.1% |
| Shiv Aum Steels Limited | ₹761 Cr | 102.4 | 5.96% | ₹146 Cr | +80.0% |
| State Trading Corporation Of India Ltd. | ₹641 Cr | 25.3 | -0.54% | ₹0 Cr | -27.2% |
| Uniphos Enterprises Ltd. | ₹602 Cr | 29.1 | 0.80% | ₹0 Cr | -44.5% |
| Genpharmasec Ltd | ₹59 Cr | 34.8 | 0.86% | ₹45 Cr | -44.1% |
Listed by market capitalisation. Ratios are shown for context only.
Genpharmasec Ltd is trading at ₹0.99, with a market capitalisation of ₹59 Cr.
Genpharmasec Ltd operates in the Industrials > Capital Goods > Trading Companies and Distributors space (Trading Companies and Distributors > Chemical Distribution).
Genpharmasec Ltd has a P/E of 34.8 and a return on equity of 0.86%.
Genpharmasec Ltd is listed on the BSE under the scrip code 531592.
Genpharmasec Ltd's share price is down 44.1% over one year and down 2.9% over three months. Its 52-week range is ₹0.76 to ₹1.84.
In Q1 FY27, Genpharmasec Ltd reported revenue of ₹45 Cr and net profit of ₹2 Cr, with basic EPS of ₹0.03 (standalone, parsed from the company's exchange filing).
Data as of 25 Oct 2026. Descriptive market data only — not investment advice.